Mesoblast Limited (MESO:NASDAQ) jumped higher at $17.88, representing a gain of 51.4%. The stock got featured on our News Catalysts scanner on Fri 14 Aug 20 at 03:31 PM in the 'BIOTECH' category.
About Mesoblast Limited (MESO:NASDAQ)
Mesoblast Ltd is engaged in the development of biologic products for the broad field of regenerative medicine. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells.
Top 10 Gainers:
- Sky Solar Holdings, Ltd. (SKYS:NASDAQ), 51.91%
- Mesoblast Limited (MESO:NASDAQ), 51.4%
- Town Sports International Holdings, Inc. (CLUB:NASDAQ), 48.43%
- Midatech Pharma plc (MTP:NASDAQ), 45.45%
- EBON (EBON:NASDAQ), 41.77%
- Farmmi, Inc. (FAMI:NASDAQ), 40.42%
- Taiwan Liposome Company, Ltd. (TLC:NASDAQ), 39.61%
- Party City Holdco Inc. (PRTY:NYSE), 28.08%
- Muscle Maker, Inc. (GRIL:NASDAQ), 26.48%
- Anchiano Therapeutics Ltd (ANCN:NASDAQ), 24.14%